Monthly Prescribing Reference

Rescue Med Combo Benefits Patients With Intermittent or Mild Persistent Asthma

The BATURA trial ended early due to high efficacy data at pre-planned analysis. Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in patients ...
Nasdaq

AIRSUPRA® (albuterol/budesonide) demonstrated statistically significant and clinically meaningful reduction in the risk of severe exacerbations in patients with intermittent ...

Independent Data Monitoring Committee recommended trial stop early due to overwhelming efficacy at pre-planned analysis AstraZeneca’s inhaled anti-inflammatory rescue medication AIRSUPRA demonstrated ...
clinicaladvisor.com

NIH releases updated asthma guidelines

The update includes new focus on monitoring asthma control as the goal for asthma therapy and distinguishing between classifying asthma severity and monitoring asthma control Emphasis is placed on ...
Healio

Discovery of pediatric patients with low-risk mild asthma may warrant guideline adjustment

Please provide your email address to receive an email when new articles are posted on . Significantly fewer pediatric patients with low- vs. high-risk intermittent asthma had an ED visit and inhaled ...